What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
The scientist’s investigation covers issues in Genetics, Colorectal cancer, Single-nucleotide polymorphism, Internal medicine and Genotype.
His Colorectal cancer study is related to the wider topic of Cancer.
His work deals with themes such as Untranslated region and Locus, which intersect with Single-nucleotide polymorphism.
His Internal medicine study integrates concerns from other disciplines, such as Personalized medicine, Bioinformatics and Oncology.
When carried out as part of a general Oncology research project, his work on Adjuvant is frequently linked to work in Molecular level, therefore connecting diverse disciplines of study.
His work is dedicated to discovering how Genotype, Odds ratio are connected with Endocrinology and Polymorphism and other disciplines.
His most cited work include:
- A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3 (497 citations)
- Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer (248 citations)
- Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA (220 citations)
What are the main themes of his work throughout his whole career to date?
Pavel Vodicka spends much of his time researching Colorectal cancer, Internal medicine, Oncology, Genetics and Single-nucleotide polymorphism.
His Colorectal cancer study is concerned with the field of Cancer as a whole.
Pavel Vodicka has included themes like Gastroenterology and Endocrinology in his Internal medicine study.
His Oncology research incorporates elements of Epidemiology, Proportional hazards model, Treatment response, Breast cancer and Cohort.
His Single-nucleotide polymorphism research is multidisciplinary, relying on both Locus, Pancreatic disease and Bioinformatics.
His Genome-wide association study study combines topics in areas such as Genetic association and Medical genetics.
He most often published in these fields:
- Colorectal cancer (90.02%)
- Internal medicine (70.78%)
- Oncology (63.18%)
What were the highlights of his more recent work (between 2018-2021)?
- Colorectal cancer (90.02%)
- Internal medicine (70.78%)
- Oncology (63.18%)
In recent papers he was focusing on the following fields of study:
His main research concerns Colorectal cancer, Internal medicine, Oncology, Cancer and Cancer research.
His Colorectal cancer research integrates issues from Cancer cell, Genome-wide association study, Carcinogenesis and Primary tumor.
His Genome-wide association study study results in a more complete grasp of Genetics.
His Oncology research is multidisciplinary, incorporating perspectives in Odds ratio, Epidemiology, Breast cancer, Single-nucleotide polymorphism and Pancreatic disease.
His work focuses on many connections between Cancer and other disciplines, such as Mendelian Randomization Analysis, that overlap with his field of interest in Biobank.
The various areas that Pavel Vodicka examines in his Cancer research study include DNA damage, Expression quantitative trait loci, Metastasis, DNA repair and Epigenetics.
Between 2018 and 2021, his most popular works were:
- Discovery of common and rare genetic risk variants for colorectal cancer (131 citations)
- Discovery of common and rare genetic risk variants for colorectal cancer (131 citations)
- Circulating biomarkers for early detection and clinical management of colorectal cancer. (52 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His primary areas of investigation include Colorectal cancer, Internal medicine, Oncology, Cancer and Genome-wide association study.
His study in Colorectal cancer is interdisciplinary in nature, drawing from both Cancer research, Fluorouracil, DNA damage and Genotype.
His study in the field of Odds ratio, Treatment response, Family history and Liquid biopsy also crosses realms of Cell-free fetal DNA.
His Oncology study combines topics in areas such as Pancreatic cancer, Single-nucleotide polymorphism, Linkage disequilibrium, Disease and Pancreatic disease.
His studies deal with areas such as Telomere, Transcriptome, Computational biology and DNA repair as well as Cancer.
His research integrates issues of Unknown Significance, Case-control study and Mutation in his study of Genome-wide association study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
